Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
25 results
- 2상모집 중· Primary Brain TumorBRAF 변이 고형암 환자에서 벨바라페닙의 중추신경계 효과 평가
Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors
협력: 한미약품
- 2상모집 중· Type 2 Diabetes Mellitus제2형 당뇨병 대상자에서 HM15275 평가 연구
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
리드: 한미약품
- 2상모집 중· Advanced or Metastatic MelanomaBelvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
리드: 한미약품
- 2상모집 중단 (진행 중)· ObeseStudy to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
리드: 한미약품
- 2상모집 중단 (진행 중)· Congenital HyperinsulinismHM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
리드: 한미약품
- 2상모집 중· Short Bowel SyndromePhase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
리드: 한미약품
- 2상완료· Gastric CancerFLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer
리드: 한미약품
- 2상완료· HypertensionA Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
리드: 한미약품
- 2상완료· NASH - Nonalcoholic SteatohepatitisStudy to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects
리드: 한미약품
- 2상완료· Non Small Cell Lung CancerOlmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA
협력: 한미약품
- 2상조기 종료· Non Small Cell Lung CancerPhase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung
리드: 한미약품
- 2상완료· Metastatic Breast CancerPoziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens
리드: 한미약품
- 2상완료· Non Small Cell Lung CancerPhase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy
리드: 한미약품
- 2상완료· Type 2 DiabetesGlycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
리드: 한미약품
- 2상완료· Type 2 DiabetesGlycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
리드: 한미약품
- 2상조기 종료· Adenocarcinoma of Lung Stage IIIBNOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma
협력: 한미약품
- 2상완료· Increased Drug ResistanceNOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors
협력: 한미약품
- 2상완료· Adult Growth Hormone DeficiencySafety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients
리드: 한미약품
- 2상완료· Irritable Bowel Syndrome Without DiarrheaExploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea
리드: 한미약품
- 2상완료· HypertensionEfficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension
리드: 한미약품
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.